Category: Pharmacy

Study: VA Clinicians Should Consider Antibiotic Risks Before Prescribing

Study: VA Clinicians Should Consider Antibiotic Risks Before Prescribing

By Brenda L. Mooney COLUMBIA, SC — Veterans prescribed amoxicillin over a nearly 13-year period were less likely to be diagnosed with potentially fatal heart rhythms than those using either azithromycin or levofloxacin, according to new research. The study, published… Read More

Uniformed Pharmacists Take Half of Next Generation Pharmacist Awards

By Annette M. Boyle LAS VEGAS, NV — Of the 30 finalists in this year’s Next Generation Pharmacist awards, 30% worked in military or public health pharmacies, the strongest representation seen in the awards program. Even more telling, uniformed pharmacists… Read More

First-in-Class Product Approved for Rosacea-Caused Facial Redness

FT. WORTH, TX — The first treatment for facial erythema in adults caused by rosacea has been approved by the Food and Drug Administration. Galderma Laboratories announced the approval of Mirvaso (brimonidine) topical gel, 0.33%* for the topical treatment of… Read More

Expanded Options Available for Metastatic Pancreatic Cancer Treatment

SUMMIT, NJ — The approved uses of Abraxane — paclitaxel protein-bound particles for injectable suspension, albumin-bound — have been expanded by the Food and Drug Administration to treat patients with metastatic pancreatic cancer in late stages. “Patients with pancreatic cancer… Read More

New Therapy Approved for Adults Suffering Major Depressive Disorder

DEERFIELD, IL — Brintellix (vortioxetine) has been approved by the Food and Drug Administration to treat adults with major depressive disorder (MDD). “Major depressive disorder can be disabling and can keep a person from functioning normally,” said Mitchell Mathis, MD,… Read More

Closed System Transfer Device Reduces Chemotherapy Drug Waste

Michael S. Edwards, PharmD By Annette M. Boyle BETHESDA, MD — With increasing shortages of critical chemotherapy drugs – and the funds to buy them – VA pharmacists are constantly looking for ways to enable the medications and money to… Read More

New Procedures for Navy Pharmacy Save More than $35 Million, Improve Care

By Annette M. Boyle Capt. Edward C. Norton, MSC, pharmacy specialty leader for U.S. Navy Bureau of Medicine and Surgery FALLS CHURCH, VA — After saving $22 million in Phase One, the Navy Pharmacy Financial Improvement Program has expanded from… Read More

New Therapies Approved for Metastatic, Unresectable Melanoma

RESEARCH TRIANGLE PARK, NC – Two new therapies, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved for patients with metastatic or unresectable melanoma, according to the Food and Drug Administration. Tafinlar, a BRAF inhibitor, is approved to treat patients with… Read More

First A1c Test Approved for Diagnosing Diabetes

INDIANAPOLIS, IN – For the first time, the U.S. Food and Drug Administration is allowing marketing of an HbA1c test specifically for diagnosing diabetes. Approval was given for the Cobas Integra 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay), manufactured by… Read More

Antibiotic Vibativ Now Approved for Treating HABP/VABP

SAN FRANCISCO – The antibiotic Vibativ (telavancin) is now approved to treat patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by Staphylococcus aureus. Vibativ should be used for the treatment of HABP/VABP only when alternative treatments are not suitable,… Read More

Oral Treatment for Opioid-Induced Constipation Approved

DEERFIELD, IL – Lubiprostone, marketed as Amitiza by Sucampo Pharmaceuticals Inc. and its partner Takeda Pharmaceuticals USA Inc., has been approved by the Food and Drug Administration (FDA) as the first oral treatment for opioid-induced constipation in adults with chronic… Read More

Simponi Also Approved for Treatment of Ulcerative Colitis

HORSHAM, PA – A new treatment is available for adults with moderate to severe ulcerative colitis. The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection, which works by blocking tumor necrosis factor (TNF). Simponi… Read More

New Option Approved for Long-Term COPD Treatment

RESEARCH TRIANGLE PARK, NC – The Food and Drug Administration has approved the first once-daily, inhaled corticosteroid/long-acting beta2 agonist (ICS/LABA) combination for the long-term, maintenance treatment of airflow obstruction in patients with COPD. Fluticasone furoate and vilanterol inhalation powder, marketed… Read More

Newly-Approved Anticoagulants Offer More Options, Different Risks

Annette M. Boyle Dr. Alan Jacobson, MD, Director of the anti-coagulation services at the Loma Linda, CA, Veterans Administration Medical Center BOSTON – While newer anticoagulants provide options for many patients with atrial fibrillation (AF) who are at risk for… Read More

New VA Study Takes Issue with FDA’s Warnings about Citalopram

By Brenda L. Mooney ANN ARBOR, MI — For nearly two years, the Food and Drug Administration has been issuing safety advisories about the risks of abnormal heart rhythms with higher doses of the antidepressant citalopram hydrobromide. A new study… Read More

Diclegis Is Only Drug Approved for Nausea, Vomiting in Pregnant Women

BLAINVILLE, QUEBEC – Diclegis (doxylamine succinate and pyridoxine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat pregnant women experiencing nausea and vomiting. It currently is the only approved treatment for those symptoms during pregnancy, the… Read More

First Lymph Node Mapping Drug Approved in More than 30 Years

DUBLIN, OH – The U.S. Food and Drug Administration recently approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, the first new drug used for lymph node mapping to be approved in more than 30 years. Lymphoseek is a radioactive diagnostic imaging… Read More

FDA Approves Tecfidera for Treatment of Relapsing MS

WESTON, MA – The U.S. Food and Drug Administration has approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS). “No drug provides a cure for multiple sclerosis, so it is important to have a… Read More

The PhARMD Program: Documenting Pharmacist Impact on VA Patient Outcomes

By Annette M. Boyle WEST PALM BEACH, FL – How much of a role are clinical pharmacists playing in patient care at VA? Since December 2011, the Pharmacists Achieve Results with Medications Demonstration (PhARMD) program has sought to answer that… Read More

Stivarga Approved for Some Stromal Tumors After Use of First-Line Therapies

WAYNE, NJ – Tthe U.S. Food and Drug Administration (FDA) has approved Bayer’s Stivarga (regorafenib) tablets to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate,… Read More